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Abstract We have employed a frameless localization
system for intracranial radiosurgery, utilizing a custom
biteblock with fiducial markers and an infra-red camera for
set-up and monitoring patient position. For multiple brain
metastases or large irregular lesions, we use a single-iso-
center intensity-modulated approach. We report our quality
assurance measurements and our experience using Intensity
Modulated Radiosurgery (IMRS) to treat such intracranial
lesions. A phantom with integrated targets and fiducial
markers was utilized to test the positional accuracy of the
system. The frameless localization system was used for
patient setup and target localization as well as for motion
monitoring during treatment. Inverse optimization planning
gave satisfactory dose coverage and critical organ sparing.
Patient setup was guided by the infrared camera through fine
adjustment in three translational and three rotational degrees
for isocenter localization and verified by orthogonal kilo-
voltage (kV) images, taken before treatment to ensure the
accuracy of treatment. The relative localization of the cam-
era based system was verified to be highly accurate along
three translational directions of couch motion and couch
rotation. After verification, we began treating patients with
this technique. About 8–12 properly selected fixed beams
with a single isocenter were sufficient to achieve good dose
coverage and organ sparing. Portal dosimetry with an Elec-
tronic Portal Imaging Device (EPID) and kV images pro-
vided excellent quality assurance for the IMRS plan and
patient setup. The treatment time was less than 60 min to
deliver doses of 16–20 Gy in a single fraction. The camera-
based system was verified for positional accuracy and was
deemed sufficiently accurate for stereotactic treatments.
Single isocenter IMRS treatment of multiple brain metasta-
ses or large irregular lesions can be done within an acceptable
treatment time and gives the benefits of dose-conformity and
organ-sparing, easy plan QA, and patient setup verification.
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Introduction
Radiosurgery has a well-established role in the treatment of
intracranial neoplasms both benign and malignant [1–6].
Initially developed by Lars Leksell, the Gamma Knife
remains the oldest treatment method and the gold standard
for intracranial radiosurgical treatments [7]. As linear
accelerator (linac) technology has advanced, however,
linac-based radiosurgery has been increasingly adopted [8,
9]. Similar to Gamma Knife treatment, linac-based radi-
osurgery has generally been performed using a frame-based
system to provide stereotactic guidance.
In order to provide assurance of both patient immobi-
lization and positioning, stereotactic radiosurgery (SRS)
has required the patient to have a rigid head-frame affixed
to the calvarium. The use of this system provides a
3-dimensional coordinate grid within which any point can
be reliably located through the use of the external system
alone. This frame is secured using four pins which screw
into the calvarium and provide a means for attaching the
frame to the treatment table. Patients are generally required
to wear this frame for 7–8 h as imaging and treatment
planning is performed just prior to treatment delivery.
Treatments usually last 15 min per isocenter with mean
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values for total treatment times on Gamma Knife Model
B, C, and Perfexion recently reported to be 131.0, 129.4,
and 114.8 min, respectively [10].
A recently-developed technology allowing frameless
intracranial radiosurgery has been described [11–14]. This
treatment offers the allure of avoiding the rigid head frame,
with the potential negative of diminished positioning
accuracy. Clearly, the accuracy of detecting and reporting
of fiducial positions by the camera system plays a crucial
role in the SRS or Intensity Modulated Radiosurgery
(IMRS) procedure [15, 16]. A systematic investigation to
quantify the accuracy of the infra-red camera system is
therefore of great importance. We describe here the accu-
racy of such a system, as well as our use of the system for
the treatment of multiple intracranial target lesions or large
irregularly-shaped lesions [17, 18].
Methods and materials
The frameless system consists of several components. For
each patient, a customized bite-block is made using a dental
tray filled with dental cement. After the bite-block is made,
a rigid array of four reflective markers is attached to the
block. These fiducial markers can be tracked by an infrared
camera mounted in the treatment vault (Fig. 1) and are used
to determine the planned isocenter position relative to the
isocenter of the treatment machine in units of 0.1 mm. After
the bite-block has been made, the patient is taken to the
treatment vault for verification of reproducibility. In the
vault, the patient is fitted with a Reseat Verification Jig,
which consists of a head band with a set of reference
markers attached. The bite-block is inserted and removed
from the patient’s mouth ten times, with the optical guid-
ance camera measuring the relative position of the biteblock
fiducials and the headband fiducials to determine the repo-
sitioning error. Acceptable variation is arbitrarily deter-
mined; we have generally accepted \0.75 mm for the
average of all ten measurements. Patients with large reseat
verification error may use a larger margin in the planning
target volume (PTV) or switch to intensity modulated
radiation treatment (IMRT) utilizing kV imaging or cone-
beam computerized tomography (CBCT) for localization.
After reseat verification, the patient proceeds to CT
(computed tomography) simulation with the bite-block in
position. For better tumor delineation, the CT image set is
fused with magnetic resonance (MR) images. Since the
immobilization head mask and the bite-block are not used
in the MR scan, it can be scheduled before or after CT
simulation. The treatment plan is done using a single iso-
center and multiple static IMRT beams. The treatment
plan, together with the CT images, is sent to the optical
guidance computer, where the fiducial locations can be
digitized. During treatment delivery, the optical guidance
camera tracks the positions of the fiducial markers in real
time, and treatment delivery can be manually interrupted
by the therapist, if a significant positioning error is
observed. We have used a threshold of 0.5–0.75 mm for
treatment interruption and repositioning. Therapists may
enter the treatment room to re-adjust the patient position
using the optical guidance system.
The frameless system serves two purposes. First, the
system can be used for initial patient positioning. The
system tracks the positions of the fiducial array for a patient
Fig. 1 A customized bite tray
of dental impressions with
attached fiducial array (left
panel). An infra-red camera
mounted on the ceiling to track
the position of the optical
reflective fiducials (right panel)
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and compares them with the positions localized in the
planning CT, as well as pre-calibrated data to determine
the target location relative to the isocenter of the treatment
machine. Second, the optical guidance camera monitors
intrafraction motion by continually assessing the positions
of the reflective fiducial markers, allowing treatment
interruption in the event of an unacceptable change in
patient position.
Initial quality assurance procedures
The phantom experiment of localization accuracy with
infra-red optical guidance was carried out by Bova et al.
[18, 19]. Our systematic study on the quality assurance has
further verified their early results. A phantom with an
integrated target and fiducial markers was mounted either
on the treatment couch or on a Brown–Roberts–Wells
(BRW) stereotactic floor stand, which enabled positioning
with sub-millimeter accuracy near the machine isocenter
(Fig. 2). Prior to the phantom study, the camera calibration
is first performed using a precise calibration jig that con-
tains reflective markers, which establishes the registration
of the optical guidance system with the isocenter of the
linac. This procedure is also a prerequisite to each patient
treatment.
After making known shifts with the floor stand along the
lateral, longitudinal and vertical directions, the reported
position from the camera system was recorded. The same
procedure was then repeated with the phantom mounted to
the couch for greater lateral shifts. Finally, the couch was
set at angles based on the camera readings and the digital
couch rotations were recorded.
Implementation of patient treatments
After confirming the positional accuracy of the optical
guidance system, we began to use the system for radio-
surgical treatment of patients. Treatment planning was
done using axial images from both a treatment planning
MR and CT. Both MR and CT scans were done at 1.25 mm
spacing and a 512 9 512 matrix size. A 1.25 mm interval
was selected, because the entire head, including the bite-
block, must be included in the imaging field. Although we
feel that this will not compromise our accuracy, slight
differences may be observed in comparison to studies
that use 1.0 mm spacing. The MR series used was a T1
weighted post-contrast image set; no intravenous or oral
contrast was used for acquisition of the CT images. The
fusion of MR and CT was carried out in the FastPlan
System (Varian Medical Systems, Palo Alto, CA) and the
adequacy of the fusion was confirmed visually by the
treating neurosurgeon. The fused image sets were exported
to the Varian Eclipse Treatment Planning System for IMRS
planning.
Target lesions as well as critical organs-at-risk (OAR)
were segmented manually. Critical structures included:
bilateral eyes and optic nerves, optic chiasm, brainstem, as
well as uninvolved brain. The clinical target volume (CTV)
consisted of all visualized tumor on either image set. A
2 mm margin was normally added to create a PTV, and
Fig. 2 A phantom of integrated
target and fiducials was
mounted either on the treatment
couch (right panel), or on a
BRW floor stand which can
position the phantom near the
isocenter with sub-millimeter
accuracy (left panel)
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reduced to 1 mm if close to a critical organ. For patients
with a larger reseating verification error ([0.75 mm), a
margin of 3 mm may be used. A single isocenter was
used to treat multiple lesions, with 8–12 carefully selected
beams with fixed gantry angles. The number of lesions
treated with a single isocenter ranged from 1 to 13. Pre-
scribed doses were 16–20 Gy with appropriate isodose
selection by the treating physician based on the volume:
16 Gy for large lesions and 20 Gy for smaller lesions,
following the monograph of the Radiosurgery Dose–Vol-
ume Relationship similar to what is used in Gamma Knife
treatments. The prescription dose was to the PTV. An
isodose line of 88–93% was normally selected to cover 95–
98% of the PTV. The gantry angle and couch rotation of
each beam was carefully selected and evaluated in the
beam’s eye view (BEV) to provide optimal organ sparing
and target coverage. All the beams were designed to have
minimal overlap with each other and, as a whole, covered a
solid angle as large as possible.
The sliding-window technique was used in all the
IMRS delivery, with a selected dose rate of 1000 MU/min;
maximum MU per beam is 1999 and maximum field size
(jaw setting) is 15 cm 9 15 cm. It was found that with
proper gantry and couch orientations, the field size of
15 cm 9 15 cm could cover almost all of the lesions. In
case a lesion was not covered properly by one beam, it
could still be covered by other beams at different orienta-
tions. For patient-related IMRT quality assurance, the
planar dose distribution was verified for each beam using
portal dosimetry on an as 1000 EPID detector prior to
patient treatment [19, 20].
In treatment planning, two orthogonal beams with digi-
tally reconstructed radiographs (DRR) were created in the
IMRS plan. At the time of patient treatment, the optical
guidance system was used for initial patient positioning.
Additionally, a pair of orthogonal kV images was acquired
using On-Board Imaging (OBI) prior to treatment. These
were compared to the DRRs from treatment planning for
further validation of patient setup (Fig. 3). The use of these
images allows detection of a misplaced or unseated bite-
block which might not otherwise be detected and could lead
to inaccurate localization of the target and mistreatment.
Results
The results of our initial quality assurance investigation are
shown in Fig. 4. The relationship between the actual known
directional shifts and the measured shifts from the optical
guidance camera readings is shown in each curve. The four
curves represent lateral, longitudinal, vertical and rotational
shifts. As the test target of the phantom is positioned at the
linac isocenter, the camera readings are all at zero values,
while the floor stand has lateral position at 0.0 cm and the
digital couch position at lateral 996.2 cm, longitudinal
66.9 cm, vertical 22.1 cm, and rotation at 0.08 angle. The
floor stand readings with a resolution of 0.1 mm are
reported along the lateral direction only from 0 to 1 cm. The
resolution of the couch digital readings are 1 mm along all
three directions, and 0.18 in couch rotation.
In order to combine the results from the floor stand and
the couch mount, the lateral home position of the couch is
re-set to 0.0 cm, and the right and left shifts given either by
floor stand or by couch, as well as the camera readings, are
all converted to positive numbers and plotted together in
Fig. 4a. The correlation of lateral shifts of camera readings
and actual known shifts yields a perfect match of a straight
line in Fig. 4a, of a slope = 1 with R2 = 1. The same
approach is applied to the longitudinal shifts in Fig. 4b and
rotational in Fig. 4d. The vertical couch home position is
kept unchanged at 22.1 cm such that the up and down shifts
are separated in Fig. 4c. In each measurement, the corre-
lation results in a straight line of a slope = 1 with R2 = 1.
The resolution of the camera readings is 0.1 mm in all
three translational directions and 0.1 degree in rotational
axes. The excellent agreement of the camera system and
the actual fiducial positions confirmed the accuracy of the
optical guided frameless positioning system. The utiliza-
tion of portal dosimetry and kV images as verification
provided further quality assurance for the IMRS plan and
patient setup.
After verification of accuracy, we began treating
patients with this technique. Two treatment plans for
patients treated with our single-isocenter IMRS technique
are shown in Fig. 5 as representative cases. One patient
has three distinct lesions, including one of an irregular
shape (top panel), with a combined CTV of 14.46 cc.
Each lesion was segmented separately, and the PTV
consists of all three lesions together with a 2 mm margin,
resulting in a total volume of 23.98 cc. 16 Gy was pre-
scribed to the combined PTV. The mean dose to normal
brain and brainstem were 3.2 and 0.6 Gy, respectively.
Eyes, optic nerves, and chiasm all received minimal dose
(\0.01 Gy). The top right pane shows the excellent tumor
coverage and relative sparing of OAR achieved with a
single-isocenter plan. The bottom two panes show the
plan for a patient treated to 12 lesions. Again these were
contoured separately and together formed the PTV with a
total volume of 15.98 cc, where a 3 mm margin was
added to the original CTV of 3.8 cc. 16 cGy was pre-
scribed to the combined PTV for this patient. In addition,
at the bottom right is shown the portal dosimetry done for
quality assurance on the IMRS plan using the Electronic
Portal Imaging Device (EPID).
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Discussion
Stereotactic guidance provides a reliable and reproducible
surrogate through which any point can be accurately
localized. The use of a rigid head frame maintains stability
in positioning, preventing patient motion during treatment
delivery. This system allows for confidence in the accurate
delivery of very high doses to target lesions with very small
expansions for setup uncertainty [21]. However, many
patients are resistant to the head frame, and there is mor-
bidity associated with its use. Frameless radiosurgery can
offer the patient the advantages of high-dose, single-frac-
tion treatment without requiring the head frame. Reported
experience with frameless radiosurgery remains limited.
The largest series to date includes 64 patients, most of
whom also received surgical resection, whole brain radia-
tion treatment, or both. In this series, overall local control
was similar to that reported for frame-based radiosurgery at
88% [14, 22–24]. Treatment plans on this frameless series
employed 1–7 isocenters and 5–35 treatment arcs.
Instead of a multiple-isocenter approach, we have used
a single-isocenter, intensity modulated approach for the
treatment of patients with multiple intracranial targets or
large, irregularly shaped targets. In all cases a single
treatment fraction was able to deliver adequate target
coverage and sparing of nearby critical normal structures.
In a previous analysis of ten patients treated with our
single-isocenter technique, the median maximal and
minimal PTV coverage was found to be 107 and 87%,
respectively, with a median integral dose to normal brain
Fig. 3 AP (a) and lateral (b) DRR, setup images, and blended images used for setup verification at the time of treatment delivery
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of 6.2 Gy [25]. Additionally, in a side-by-side comparison
of a patient planned using both a single- and multiple-
isocenter approach, median integral dose to brain was 4.5
and 1.6 Gy for a single- versus multiple-isocenter plan,
respectively. Toxicity was found to be generally mild and
acceptable. These previous results in combination with
our current quality assurance analysis suggest that this
technique may offer a more streamlined approach to
treatment planning without compromising the quality of
treatment.
As a comparison, the hot spot inside the PTV of
an IMRS plan is typically 15–20% greater than the pre-
scribed dose, whereas the dose to the center of each
lesion is twice greater than the prescribed dose in Gamma
Knife and 20% or higher in cone-based arc linac plans.
On the other hand, the dose fall-off outside PTV in IMRS
plans is less rapid than that in Gamma Knife or in a
cone based arc plan, causing the integral dose to normal
brain to be slightly higher with IMRS. These observations
are better demonstrated in dose–volume histograms
(DVH) from PTV and normal brain for IMRS plans,
such as those shown in Fig. 5. Although integral dose to
normal brain was increased, the clinical significance of
this elevation is unclear. Treatment with single-isocenter
IMRS was well-tolerated, with minimal acute toxicity
reported by our patients in this series. Long-term assess-
ment of post-IMRS patients, including an analysis of local
control, toxicity, and survival outcomes, is currently
underway and will help to define the true benefits and
risks of this technique.
The use of a frameless technique offers additional
patient convenience. Many patients are resistant to the
head frame, and find it difficult to wear for the number of
hours required. Frameless techniques not only alleviate
this problem for single-fraction treatments, but also offer
the option of hypofractionated treatment or single-fraction
treatment done on a separate day from treatment planning
[26]. In addition, the total treatment time for patient setup
Fig. 4 Correlation of measurement of lateral, longitudinal, and
vertical (a–c) shifts between camera readings and actual shifts given
either by a floor stand (lateral only) or couch digital readout (all
directions). The home couch positions are re-set to 0 and shifts in
either direction of axis are combined in the graphs of a and b. In c, the
vertical home position of 221 mm is kept unchanged and up and
down shifts are not combined. The clockwise (CW) and counter-
clockwise rotation of the couch are again combined in d. CCW
rotation were carried out in increment of 18 each till 58, and then
changed to every 108, and up to 90, while the CW rotation was done
in every 108
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validation and dose delivery was about 45 min to deliver
doses of 16–20 Gy in each case. Patients with larger PTV
can be treated with multiple fractions, typically of a
prescription dose 6 Gy per fraction, a total of 30 Gy
delivered in five fractions, which is made possible only by
the use of frameless localization system.
Our quality assurance procedures have shown the optical
guidance system to be accurate and reliable; a further
advantage of its use is the ability for intrafraction monitoring
of patient position. The system allows for treatment inter-
ruption if the measured displacement of the fiducial markers
is outside the predetermined tolerances.
The patient setup, after target localization through the
optical guidance camera system, is verified by the orthog-
onal KV-image pair using OBI and comparing with the DRR
images. KV image–DRR comparison serves as a verification
tool to ensure patient positioning accuracy prior to the
radiation treatment and is not routinely used as a patient
repositioning tool in the IMRS treatment.
In some cases, due to issues with bite-block reseating,
where isocenter misalignment is identified as 2 mm or
greater when matching KV images with DRRs, patient
treatment may proceed as IMRT treatment without utiliz-
ing the optical guidance system. This is a clinical decision,
made after images have been reviewed by therapist,
physicist, and physician together, and the patient is
re-positioned based on OBI to make isocenter shift prior to
the radiation treatment.
For patients with dentures, we have found that with the
help of denture adhesive treatment can proceed with CT
simulation and keep the reproducibility at treatment. This
frameless immobilization may not be suitable to those who
can not hold the bite block in place. For those patients,
IMRT treatment may be a better approach.
Conclusion
Ours is a novel strategy-frameless radiosurgical simulta-
neous treatment of multiple intracranial targets with a
single-isocenter intensity modulated plan. We believe this
is an appealing alternative to conventional frame-based
systems, offering both convenience and comfort to patients
while maintaining overall plan quality.
Fig. 5 The IMRS plan of a patient with three lesions (top). 16 Gy
was prescribed to the combined PTV. The normal brain and brainstem
are shown in light blue and orange. At bottom is the IMRS plan of a
patient with 12 lesions. The quality assurance of IMRS plans was
done by portal dosimetry as shown in the lower right. The solid lines
represent the calculated planar dose distributions and the dotted lines
the measured dose using EPID. The horizontal profile of such planar
dose distribution of one beam is displayed, where the superimposed
curves represent the calculated and measured dose profiles (Color
figure online)
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